ALNY Financial Facts

Net loss per common share - basic and diluted: -0.15
General and administrative: 6.27M
See Full Income Statement

Accounts payable: 3.11M
Marketable securities: 138.21M
See Full Balance Sheet

Earnings History for Alnylam Pharmaceuticals, Inc. (ALNY)

  |   Expand Research on ALNY
Next EPS Date 8/5/13 *Est. EPS Growth Rate +40.0% *Last Qtr.
Average EPS % Beat Rate +8.1% Revenue Growth Rate -9.7% *Last Qtr.
Average % Move 1-Wk after EPS +1.5%    
Date  Qtr EPS Cons. Surprise Revs Cons. Estimize EPS/Revs Gd. % Since Details
5/6/13 Q113 -$0.15-$0.29 +$0.14$18.6M$15.56M N/A / N/A N/A +27.1% Details
2/7/13 Q412 -$1.20-$1.48 +$0.28$8.5M$15.82M N/A / N/A N/A +27% Details
11/5/12 Q312 -$0.31-$0.30 -$0.01$16.8M$17M N/A / N/A N/A +81% Details
8/6/12 Q212 -$0.25-$0.19 -$0.06$20.9M$20.81M N/A / N/A N/A +63.3% Details
5/3/12 Q112 -$0.25-$0.36 +$0.11$20.6M$19.57M N/A / N/A N/A +194% Details
2/9/12 Q411 -$0.33-$0.32 -$0.01$20.5M$20.9M N/A / N/A N/A +132% Details
11/1/11 Q311 -$0.31-$0.35 +$0.04$20.8M$20.51M N/A / N/A N/A +291.3% Details
8/1/11 Q211 -$0.33-$0.36 +$0.03$20.6M$19.97M N/A / N/A N/A +220.8% Details
Like ALNY Earnings? Also take a look at SNY, MDCO, ISIS, TKMR

ALNY Earnings News